These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3117593)

  • 1. Follicular stimulation for in vitro fertilization using pituitary suppression and human menopausal gonadotropins.
    Awadalla SG; Friedman CI; Chin NW; Dodds W; Park JM; Kim MH
    Fertil Steril; 1987 Nov; 48(5):811-5. PubMed ID: 3117593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.
    Cummins JM; Yovich JM; Edirisinghe WR; Yovich JL
    J In Vitro Fert Embryo Transf; 1989 Dec; 6(6):345-52. PubMed ID: 2517507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and follicular fluid (FF) estradiol (E2) levels in ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) conception cycles after pituitary suppression.
    Leya J; Molo MW; Olson D; Radwanska E
    J In Vitro Fert Embryo Transf; 1991 Jun; 8(3):137-40. PubMed ID: 1919258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval.
    Meldrum DR; Wisot A; Hamilton F; Gutlay AL; Kempton WF; Huynh D
    Fertil Steril; 1989 Mar; 51(3):455-9. PubMed ID: 2493403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of the controlled ovarian hyperstimulation using GnRH agonist and pure FSH in in vitro fertilization-embryo transfer and gamete intrafallopian transfer program].
    Usui A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1431-8. PubMed ID: 2511261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer.
    Ferrier A; Rasweiler JJ; Bedford JM; Prey K; Berkeley AS
    Fertil Steril; 1990 Jul; 54(1):90-5. PubMed ID: 2113492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycles of in vitro fertilization and gamete intrafallopian transfer.
    Kubik CJ; Guzick DS; Berga SL; Zeleznik AJ
    Fertil Steril; 1990 Nov; 54(5):836-41. PubMed ID: 2121551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women.
    Dodson WC; Walmer DK; Hughes CL; Yancy SE; Haney AF
    Obstet Gynecol; 1991 Aug; 78(2):187-90. PubMed ID: 1906152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis.
    Corson SL; Batzer FR; Gocial B; Eisenberg E; Huppert LC; Nelson JR
    Fertil Steril; 1992 Mar; 57(3):601-5. PubMed ID: 1740205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success.
    Seifer DB; Thornton KL; DeCherney AH; Lavy G
    Fertil Steril; 1991 Sep; 56(3):500-4. PubMed ID: 1909977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The results of an in vitro fertilization program: two regimens of superovulation.
    Grochowski D; Wołczyński S; Kuczyński W; Kulikowski M; Szamatowicz M
    Gynecol Endocrinol; 1995 Mar; 9(1):59-62. PubMed ID: 7793301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian response and pregnancy rates in in vitro fertilization, gamete intrafallopian transfer, and in vivo fertilization therapies after combined gonadotropin-releasing hormone agonist/human menopausal gonadotropin stimulation.
    Lindner C; Braendle W; Lichtenberg V; Köhler S; Bettendorf G
    Gynecol Obstet Invest; 1990; 29(2):140-4. PubMed ID: 2139861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed occurrence of an LH surge after HCG administration during ovarian stimulation with gonadotrophins: effect of LHRH treatment.
    Rojas FJ; Moretti-Rojas I; Balmaceda JP; Asch RH
    Hum Reprod; 1989 Aug; 4(6):643-6. PubMed ID: 2506219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
    Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
    J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of short pituitary suppression with gonadotropin-releasing hormone agonist leuprolide during induction of ovulation for in vitro fertilization.
    Henig I; Chan PJ; Prough SG; Tredway DR
    J In Vitro Fert Embryo Transf; 1989 Aug; 6(4):195-200. PubMed ID: 2515234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.